Look for ‘Huge Ripple Effect’ from Drug Price Blueprint

Look for ‘Huge Ripple Effect’ from Drug Price Blueprint

American Patients First, the Trump Administration’s “blueprint to lower drug prices,” contains provisions with the potential for a “huge ripple effect” on the health care marketplace, according to Alex Jung, managing director in the Parthenon-EY practice of Ernst & Young LLP. Jung provided a policy perspective on American Patients First at The Alliance Annual Meeting on “Keeping A Lid on Specialty Rx Costs” held Sept. 11, 2018, at Monona Terrace.

Pin It on Pinterest